Skip to content

Leidos seeks industry participation for jp2060 phase 3 bid

Leidos seeks industry participation for JP2060 Phase 3 bid

Leidos Australia is calling on Australian industry participation in its response to the Joint Project 2060 (JP2060) Phase 3 Deployable Health Capability Request for Tender, expected to be released shortly.

The multi-phase JP2060 project is being led by the Capability Acquisition and Sustainment Group (CASG) within the Australian Department of Defence.

JP2060 Phase 3 seeks to acquire a transportable health capability for use in Australia and overseas. The project involves identifying and developing capabilities to prevent, treat, manage and evacuate casualties to enable best practice military medicine.

In looking to maximise potential opportunities for Australian industry, Leidos Australia is seeking a range of capabilities including:

  • transportation solutions
  • physical structures and associated infrastructure
  • medical equipment
  • dental equipment
  • warehousing support
  • logistics support.

Leidos Australia—with expertise in IT, engineering and science—is looking to connect with Industry participants who may be able to provide some or all of these capabilities. Register your interest at

For further details, please contact Leidos Australia's Senior Subcontract Administrator, Marc Williams by email

To view the original online JP 2060 Phase 3 Approach to Market for information—published November 2015—visit AusTender's website.

For more defence industry news, sign up to our free e-newsletter and follow us on Twitter.

Last updated: 16 Nov 2021